Depression News and Research

Latest Depression News and Research

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

A post-hoc analysis of a Phase 3 safety study demonstrated that NUCYNTA® (tapentadol) tablets were associated with a lower incidence of nausea, vomiting and constipation when compared to oxycodone immediate release (IR) tablets in elderly patients with moderate to severe low-back or osteoarthritis pain.

7 May 2010

New changes to 'Extra Help' program enables more people save on prescription drug costs

Medicare beneficiaries who qualify for "Extra Help" may be eligible to pay no more than $2.50 for generic drugs and $6.30 for each brand name drug thanks to changes to Medicare's Low-Income Subsidy Program for Part D prescription drug costs (also known as LIS or "Extra Help") that take effect this year. These changes make it easier than ever for people on Medicare with limited incomes to save on their drug costs.

7 May 2010

M-3 Information introduces iPhone application for depression, anxiety disorders

M-3 Information entered the smart phone application environment by offering the M-3 Checklist, a scientifically validated screen for depression and anxiety disorders, at the iTunes store on Friday, April 30, 2010. Adapted from M-3 Information's existing mymoodmonitor.com website, this mobile version, called mym3, provides the same validated mental health questionnaire optimized for smart phones. A first in iPhone applications, mym3 is designed to create a bridge between user responses and recommendations set forth in the content-rich M3 website application.

7 May 2010

DUSA Pharmaceuticals receives notice of allowance for patent covering blue light technology

DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), today announced that the United States Patent and Trademark Office has issued a notice of allowance for a key patent related to its proprietary PDT light source, the BLU-U®, Blue Light Photodynamic Therapy Illuminator.

7 May 2010

Sleep disturbance may result in negative consequences among residents of ALFs: Study

In a study of residents of Assisted Living Facilities in Los Angeles showed that 65% had clinically significant sleeping problems and that poor sleep was associated with declining quality of life and increased depression over a six month follow-up period. This study is published today in the Journal of the American Geriatrics Society.

7 May 2010

Sleep problems can increase depression and reduce quality of life in older people

In a study of residents of Assisted Living Facilities (ALFs) in Los Angeles showed that 65% had clinically significant sleeping problems and that poor sleep was associated with declining quality of life and increased depression over a six month follow-up period. This study is published today in the Journal of the American Geriatrics Society.

7 May 2010

Biovail reports 27% increase in first-quarter 2010 total revenues

Biovail Corporation today announced its financial results for the three-month period ended March 31, 2010.

6 May 2010

New techniques to help women make decisions, increase safety during IPV

A new research study to be conducted by Johns Hopkins University School of Nursing associate professor Nancy Glass will help women plan for their personal safety when ending an abusive relationship.

6 May 2010

New film on depression, drugs and alternative paths to better mental health

A new film on depression, drugs and alternative paths to better mental health will premiere Wednesday, May 12th at UltraStar Cinemas in Del Mar, CA. An answer to the pharmaceutical industry's media blitz, Living Life Films' "Changing Our Minds" questions society's values while revealing interesting and disturbing truths about psychiatry and the drug industry.

6 May 2010

Labopharm's first-quarter fiscal 2010 revenues from product sales decrease $0.4M to $3.2M

Labopharm Inc. today reported its financial results for the first quarter 2010.

6 May 2010

Sermo Category Report: About 30% of patients suffer from depression

Sermo, the world's largest online community for physicians, today announced a Sermo Category Report titled Antidepressant Treatment Behaviors. The report surveyed more than 200 primary care physicians and covers a variety of topics including product choice drivers, treatment paths, referring habits, and overall issues in depression management.

6 May 2010

Researchers to identify rare genetic mutation to produce histamine against TS

A single, very unusual family with Tourette syndrome has led Yale School of Medicine researchers to identify a rare mutation in a gene that is required to produce histamine. The finding provides a new framework to understand many years of data on the role of histamine function in the brain and points to a potentially novel approach to treatment of tics and Tourette.

6 May 2010

Spouses of dementia sufferers at higher risk of developing dementia

Older married adults whose spouse has dementia are at significantly higher risk for developing dementia themselves, compared to similar older married adults whose spouse never develops dementia. This is the key finding of a study published today in the Journal of the American Geriatrics Society.

5 May 2010

Researchers analyze spine surgery patients' existing comorbdities in relationship to hospital stay, costs

It is estimated that between 75 and 85 percent of all Americans will suffer from low back pain and/or neck pain at some point in their lives. An estimated 12 million Americans suffer from degenerative disc disease, with over one million patients undergoing surgery each year. The cost of treating back pain is currently estimated at more than $100 billion annually in the U.S. Many patients with back pain have comorbidities that impact spine surgery.

5 May 2010

Ventral striatum plays important role in circuitry of reward-oriented behavior: Researchers

An estimated 26.2 percent of Americans ages 18 and older - about one in four adults - suffer from a diagnosable mental disorder every year, which equates to approximately 57.7 million adults. Severe psychiatric illness affects a much smaller number of people - about 6 percent, or 1 in 17. Worldwide, an estimated 340 million people suffer from an episode of major depression every year.

5 May 2010

Alvine Pharmaceuticals reports data of ALV003 in gastric simulation model at DDW 2010

Alvine Pharmaceuticals, Inc., today announced the reporting of scientific data on the performance of its lead compound, ALV003, in a gastric simulation model. The data were presented at the 2010 Digestive Disease Week (DDW) meeting held in New Orleans, Louisiana.

5 May 2010

Depression News and Research

Latest Depression News and Research

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

New changes to 'Extra Help' program enables more people save on prescription drug costs

M-3 Information introduces iPhone application for depression, anxiety disorders

DUSA Pharmaceuticals receives notice of allowance for patent covering blue light technology

Sleep disturbance may result in negative consequences among residents of ALFs: Study

Sleep problems can increase depression and reduce quality of life in older people

Biovail reports 27% increase in first-quarter 2010 total revenues

New techniques to help women make decisions, increase safety during IPV

New film on depression, drugs and alternative paths to better mental health

Labopharm's first-quarter fiscal 2010 revenues from product sales decrease $0.4M to $3.2M

Sermo Category Report: About 30% of patients suffer from depression

Researchers to identify rare genetic mutation to produce histamine against TS

Spouses of dementia sufferers at higher risk of developing dementia

Researchers analyze spine surgery patients' existing comorbdities in relationship to hospital stay, costs

Ventral striatum plays important role in circuitry of reward-oriented behavior: Researchers

Alvine Pharmaceuticals reports data of ALV003 in gastric simulation model at DDW 2010

Older adults with depression do not respond to emotional stimuli, says study

Anavex reports promising results from ANAVEX 2-73 Alzheimer's disease compound in animal studies

Understanding the biology of postpartum blues

Living with a dementia sufferer may affect spouse

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Depression News and Research

Latest Depression News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in